BridgeMD
New treatment option for Neuromuscular Blocking Agents
Official title Recovery Times of Half Dose Sugammadex and Neostigmine for Rocuronium-induced Neuromuscular Blockade
ClinicalTrials.gov ID: NCT06794450
What this study is testing
What is Sugammadex 1 mg/kg?
Sugammadex 1 mg/kg is an investigational medicine, given as a treatment applied to the skin, being studied as a potential treatment for neuromuscular blocking agents.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- In operating procedure with general anesthesia muscle relaxant is usually used to increase success rate of the operation and to give better outcome. The use of reversal drugs aims to reduce the risk of post-operative complications due to muscle relaxants.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 59
You may be able to join if
- Patients who underwent laparoscopic cholecystectomy under general anesthesia
- Using muscle relaxant rocuronium
- Aged 18-59 years
- American Society of Anesthesiologists (ASA) physical status classification of 1 or 2.
You likely can't join if
- History of drug allergies to the agents used
- Renal dysfunction
- Musculoskeletal disorders
- Central nervous system disorders
- Difficult airways requiring intubation without the use of muscle relaxants.
The study team makes the final eligibility decision.
Where it's taking place
- Bandung, West Java, Indonesia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 59 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bandung, West Java, Indonesia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.